Detalhe da pesquisa
1.
Metastasis suppressor genes and their role in the tumor microenvironment.
Cancer Metastasis Rev
; 42(4): 1147-1154, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37982987
2.
Therapeutic potential of the new TRIB3-mediated cell autophagy anticancer drug ABTL0812 in endometrial cancer.
Gynecol Oncol
; 153(2): 425-435, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30853360
3.
Metabolomic-Based Approaches for Endometrial Cancer Diagnosis and Prognosis: A Review.
Cancers (Basel)
; 16(1)2023 Dec 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38201612
4.
RBFOX2 deregulation promotes pancreatic cancer progression and metastasis through alternative splicing.
Nat Commun
; 14(1): 8444, 2023 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38114498
5.
Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer.
Cancers (Basel)
; 14(12)2022 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35740505
6.
ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma.
Mol Oncol
; 16(11): 2235-2259, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35167193
7.
Small-Molecule Inhibitors (SMIs) as an Effective Therapeutic Strategy for Endometrial Cancer.
Cancers (Basel)
; 12(10)2020 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32987790
8.
Transient and DNA-free in vivo CRISPR/Cas9 genome editing for flexible modeling of endometrial carcinogenesis.
Cancer Commun (Lond)
; 43(5): 620-624, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36762520